(Q37150501)

18 August 2017

1 reference

title

Latent (slowly progressing) autoimmune diabetes in adults (English)

1 reference

18 August 2017

Jochen Seissler

1

1 reference

18 August 2017

publication date

1 April 2008

1 reference

18 August 2017

published in

Current diabetes report

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

94-100

1 reference

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0018-X

Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0018-X

Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).

21 January 2018

1 reference

12 December 2020

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe

1 reference

12 December 2020

Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes

1 reference

12 December 2020

Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).

1 reference

12 December 2020

Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop fo

1 reference

12 December 2020

An association analysis of the HLA gene region in latent autoimmune diabetes in adults.

1 reference

12 December 2020

Immunomodulation for the prevention of SPIDDM and LADA.

1 reference

12 December 2020

Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.

1 reference

12 December 2020

T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.

1 reference

12 December 2020

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

1 reference

12 December 2020

Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus

1 reference

12 December 2020

Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group

1 reference

12 December 2020

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

1 reference

12 December 2020

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).

1 reference

12 December 2020

Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies

1 reference

12 December 2020

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics

1 reference

12 December 2020

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

12 December 2020

Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus

1 reference

12 December 2020

Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes

1 reference

12 December 2020

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

1 reference

12 December 2020

Autoimmune type 1 diabetes: resolved and unresolved issues

1 reference

12 December 2020

Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.

1 reference

12 December 2020

Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report

1 reference

12 December 2020

Lessons on autoimmune diabetes from animal models

1 reference

12 December 2020

Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults

1 reference

12 December 2020

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report

1 reference

12 December 2020

Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.

1 reference

12 December 2020

High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients

1 reference

12 December 2020

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).

1 reference

12 December 2020

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease

1 reference

12 December 2020

A clinical screening tool identifies autoimmune diabetes in adults

1 reference

12 December 2020

Genetic susceptibility to type 1 diabetes

1 reference

12 December 2020

Environmental factors in the development of Type 1 diabetes

1 reference

12 December 2020

Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes

1 reference

12 December 2020

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

1 reference

12 December 2020

The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults

1 reference

12 December 2020

Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults

1 reference

12 December 2020

Autoantibodies in diabetes

1 reference

12 December 2020

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77

1 reference

12 December 2020

1 reference

12 December 2020

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

1 reference

12 December 2020

GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis

1 reference

12 December 2020

Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds

1 reference

12 December 2020

High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.

1 reference

12 December 2020

Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).

1 reference

12 December 2020

10.1007/S11892-008-0018-X

Identifiers

DOI

1 reference

18 August 2017

1 reference